References
- JYPark, YHPark, DHShin, SHOh. Insulin-like growth factor binding protein (IGFBP)-mediated hair cell survival on the mouse utricle exposed to neomycin: the roles of IGFBP-4 and IGFBP-5. Acta Otolaryngol Suppl 2007;558:22–9.
- HToyota, HShimogori, KSugahara, HYamashita. A novel treatment for vestibular disorder with FGLM-NH2 plus SSSR. Neurosci Lett 2012;526:128–32.
- NChikamoto, T-IChikama, NYamada, TNishida, TIshimitsu, AKamiya. Efficacy of substance P and insulin-like growth factor-1 peptides for preventing postsurgical superficial punctate keratopathy in diabetic patients. Jpn J Ophthalmol 2009;53:464–9.
- LLCunningham. The adult mouse utricle as an in vitro preparation for studies of ototoxic-drug-induced sensory hair cell death. Brain Res 2006;1091:277–81.
- IVarela-Nieto, JAMorales-Garcia, PVigil, ADiaz-Casares, IGorospe, SSánchez-Galiano, et al. Trophic effects of insulin-like growth factor-I (IGF-I) in the inner ear. Hear Res 2004;196:19–25.
- GCamarero, CAvendano, CFernandez-Moreno, AVillar, JContreras, Fde Pablo, et al. Delayed inner ear maturation and neuronal loss in postnatal IGF-1-deficient mice. J Neurosci 2001;21:7630–41.
- KSugahara, EWRubel, LLCunningham. Jnk signaling in neomycin-induced vestibular hair cell death. Hear Res 2006;221:128–35.
- SMurillo-Cuesta, LRodríguez-de la Rosa, RCediel, LLassaletta, IVarela-Nieto. The role of insulin-like growth factor-i in the physiopathology of hearing. Front Mol Neurosci 2011;4:11.
- VLevresse, LButterfield, EZentrich, LEHeasley. Akt negatively regulates the cJun N-terminal kinase pathway in PC12 cells. J Neurosci Res 2000;62:799–808.
- TNishida, MNakamura, KOfuji, TWReid, MJMannis, CJMurphy. Synergistic effects of substance P with insulin-like growth factor-1 on epithelial migration of the cornea. J Cell Physiol 1996;169:159–66.
- TNakagawa, TSakamoto, HHiraumi, YSKikkawa, NYamamoto, KHamaguchi, et al. Topical insulin-like growth factor 1 treatment using gelatin hydrogels for glucocorticoid-resistant sudden sensorineural hearing loss: a prospective clinical trial. BMC Med 2010;8:76.
- TFujiwara, NHato, TNakagawa, YTabata, TYoshida, HKomobuchi, et al. Insulin-like growth factor 1 treatment via hydrogels rescues cochlear hair cells from ischemic injury. Neuroreport 2008;19:1585–8.
- KIwai, TNakagawa, TEndo, YMatsuoka, TKita, T-SKim, et al. Cochlear protection by local insulin-like growth factor-1 application using biodegradable hydrogel. Laryngoscope 2006;116:529–33.
- NYamada, RMatsuda, NMorishige, RYanai, T-IChikama, TNishida, et al. Open clinical study of eye-drops containing tetrapeptides derived from substance P and insulin-like growth factor-1 for treatment of persistent corneal epithelial defects associated with neurotrophic keratopathy. Br J Ophthalmol 2008;92:896–900.